This company listing is no longer active
SciClone Pharmaceuticals (Holdings) Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hong Zhao
Chief executive officer
CN¥17.0m
Total compensation
| CEO salary percentage | 45.0% |
| CEO tenure | 4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥1b |
| Sep 30 2023 | n/a | n/a | CN¥1b |
| Jun 30 2023 | n/a | n/a | CN¥953m |
| Mar 31 2023 | n/a | n/a | CN¥904m |
| Dec 31 2022 | CN¥17m | CN¥8m | CN¥855m |
| Sep 30 2022 | n/a | n/a | CN¥844m |
| Jun 30 2022 | n/a | n/a | CN¥833m |
| Mar 31 2022 | n/a | n/a | CN¥878m |
| Dec 31 2021 | CN¥26m | CN¥7m | CN¥923m |
| Sep 30 2021 | n/a | n/a | CN¥837m |
| Jun 30 2021 | n/a | n/a | CN¥779m |
| Mar 31 2021 | n/a | n/a | CN¥766m |
| Dec 31 2020 | CN¥29m | CN¥7m | CN¥754m |
| Sep 30 2020 | n/a | n/a | CN¥817m |
| Dec 31 2019 | CN¥15m | CN¥6m | CN¥615m |
Compensation vs Market: Hong's total compensation ($USD2.35M) is above average for companies of similar size in the Hong Kong market ($USD480.51K).
Compensation vs Earnings: Hong's compensation has been consistent with company performance over the past year.
CEO
Hong Zhao (61 yo)
4yrs
Tenure
CN¥17,030,000
Compensation
Mr. Hong Zhao has been President and Chief Executive Officer at SciClone Pharmaceuticals (Holdings) Limited since June 24, 2020 and also serves as its Executive Director since June 24, 2020. Mr. Zhao serve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 4yrs | CN¥17.03m | 0.18% CN¥ 20.6m | |
| Company Secretary | less than a year | no data | 0.026% CN¥ 3.0m | |
| VP & Head of Technical Operations and Pharmacovigilance | 2.4yrs | no data | no data | |
| VP & Head of Immunization Business Unit | no data | no data | no data | |
| VP and Head of Market Access & Commercial Operation (MACO) Department | no data | no data | no data | |
| VP and Head of Registration & Pharmaceutical Affairs Department | no data | no data | no data | |
| VP, GM of Research and Development & Chief Medical Officer | 2yrs | no data | no data | |
| VP & Chief Business Development Officer | less than a year | no data | no data |
2.0yrs
Average Tenure
55yo
Average Age
Experienced Management: 6600's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 4yrs | CN¥17.03m | 0.18% CN¥ 20.6m | |
| Company Secretary | 1.1yrs | no data | 0.026% CN¥ 3.0m | |
| Non-Executive Director | 3.8yrs | CN¥658.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥658.00k | no data | |
| Non-Executive Chairman | 4yrs | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥658.00k | no data | |
| Non-Executive Director | 3yrs | no data | no data | |
| Non-Executive Director | 3.3yrs | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥658.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥658.00k | no data |
3.3yrs
Average Tenure
58yo
Average Age
Experienced Board: 6600's board of directors are considered experienced (3.3 years average tenure).